Share on StockTwits

Endo International PLC (NASDAQ:ENDP) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 8,404,349 shares, a decline of 16.1% from the March 31st total of 10,011,391 shares, AnalystRatings.NET reports. Based on an average trading volume of 4,078,228 shares, the days-to-cover ratio is currently 2.1 days. Currently, 5.8% of the shares of the company are short sold.

In other Endo International PLC news, Director John Delucca unloaded 8,094 shares of the stock on the open market in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $66.31, for a total transaction of $536,713.14. The sale was disclosed in a filing with the SEC, which is available at this link.

Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Friday. They now have a $70.00 price target on the stock. Separately, analysts at Morgan Stanley upgraded shares of Endo International PLC from an “equal weight” rating to an “overweight” rating in a research note on Friday. They now have a $79.00 price target on the stock. Finally, analysts at National Alliance Securities initiated coverage on shares of Endo International PLC in a research note on Wednesday, April 30th. They set a “buy” rating and a $76.00 price target on the stock. Two analysts have rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the company’s stock. Endo International PLC has a consensus rating of “Hold” and a consensus price target of $62.79.

Endo International PLC (NASDAQ:ENDP) opened at 65.79 on Monday. Endo International PLC has a one year low of $32.66 and a one year high of $82.16. The stock’s 50-day moving average is $64.71 and its 200-day moving average is $64.64. The company’s market cap is $8.430 billion.

Endo International PLC (NASDAQ:ENDP) last announced its earnings results on Thursday, May 1st. The company reported $0.92 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.84 by $0.08. The company had revenue of $595.00 million for the quarter, compared to the consensus estimate of $608.86 million. During the same quarter last year, the company posted $1.09 earnings per share. Endo International PLC’s revenue was down 9.3% compared to the same quarter last year. On average, analysts predict that Endo International PLC will post $3.68 earnings per share for the current fiscal year.

Endo International PLC, formerly Endo Health Solutions Inc, incorporated on November 18, 1997, is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.